WCA
IDXX icon

Waratah Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Waratah Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,400
Closed -$1.01M – 194
2025
Q1 		$1.01M Buy
+2,400
New +$1.04M 0.03% 147

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Waratah Capital Advisors's IDXX Position: Q2 2026 in Review

Waratah Capital Advisors increased its Idexx Laboratories (IDXX) stake by 1,637% in Q2 2026, buying an estimated $6.59M and bringing the position to 12,474 shares worth $6.57M. The position accounts for 0.22% of the portfolio, ranked #88.

Waratah Capital Advisors first reported a position in IDXX in Q1 2018 and has held it in 21 quarters since. The position peaked at $51.8M in Q1 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Waratah Capital Advisors held 12,474 shares of Idexx Laboratories worth $6.57M as of Q2 2026.
  • Waratah Capital Advisors bought 11,756 Idexx Laboratories shares in Q2 2026, an estimated $6.59M.
  • Idexx Laboratories made up 0.22% of Waratah Capital Advisors's portfolio in Q2 2026, its #88 holding.
  • Waratah Capital Advisors first reported a position in Idexx Laboratories in Q1 2018 and has held it in 21 quarters since.
  • Waratah Capital Advisors's Idexx Laboratories position peaked at $51.8M in Q1 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Waratah Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.